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Background: Enterotoxigenic Escherichia coli (ETEC) colonize the human intestinal
mucosa using pili and non-pili colonization factors (CFs). CS21 (also designated Longus) is
one of the most prevalent CFs encoded by a 14 kb lng DNA cluster located in a virulence
plasmid of ETEC; yet limited information is available on the prevalence of CS21 positive
ETEC isolates in different countries. The aim of this study was to evaluate the prevalence
of CS21 among ETEC clinical isolates from Mexican and Bangladeshi children under 5
years old with diarrhea and to determine the phenotypic and genotypic features of these
isolates.
Methods: ETEC clinical isolates positive to lngA gene were characterized by genotype,
multidrug-resistance, self-aggregation, biofilm formation, and adherence to HT-29 cell
line.
Results: A collection of 303 E. coli clinical isolates were analyzed, the 81.51% (247/303)
were identified as ETEC, 30.76% (76/247) were st+/lt+, and 25.10% (62/247) were positive
for the lngA gene. Among the lngA+ ETECs identified, 50% of isolates (31/62) were
positive for LngA protein. The most frequent serotype was O128ac:H12 found in 19.35%
(12/62) of lngA+ ETEC studied. Multidrug-resistance (MDR) lngA+ ETEC isolates was
identified in 65% (39/60), self-aggregation in 48.38% (30/62), and biofilm formation in
83.87% (52/62). ETEC lngA+ isolates were able to adhere to HT-29 cells at different levels.
Two lngA isogenic mutants were constructed in the ETEC E9034A and ETEC73332 clinical
isolate, showing a 77% and 98% reduction in adherence, respectively with respect to the
wild type.
Conclusion: ETEC isolates that have the lngA gene showed features associated with
self-aggregation, and adherence to HT-29 cells, important characteristics in the human
gut colonization process and pathogenesis.
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INTRODUCTION
Bacterial adherence is the first and most important step in bacte-
rial infection. Diverse pathogenic mechanisms allow the bacteria
to adhere to host tissues and aggregate at the infection site with
the subsequent colonization and dissemination to other anatom-
ical sites within the host (Nataro and Kaper, 1998; Craig et al.,
2004). Enterotoxigenic Escherichia coli (ETEC), a leading trav-
eler’s diarrhea etiologic agent, also cause 300,000–500,000 deaths
annually in children under the age of 5 years living in developing
countries (WHO, 2006). Profuse watery diarrhea is the disease’s
hallmark, and similarly to cholera, it is mediated by the secre-
tion of a cholera-like heat-labile (LT) and/or heat-stable toxins
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(ST) (Nataro and Kaper, 1998). These enterotoxins are believed
to be encoded by large virulence plasmids and co-regulated with
pili and non-pili surface proteins (Brinton, 1965; Beachey, 1981).
Colonization of the small bowel mucosa by ETEC isolates is medi-
ated by a broad variety of fimbrial and non-fimbrial surface struc-
tures called colonization factors (CFs). CFs includes colonization
factor antigens (CFAs), coli surface antigens (CSs), and puta-
tive colonization factors (PCFs) (Gaastra and Svennerholm, 1996;
Nataro and Kaper, 1998). More than 25 CFs have been described
in human ETEC isolates (Qadri et al., 2005) and they are strongly
associated with ETEC infection. Evidence of the role of CFs in
pathogenesis include a study reporting that pili-less ETECs rarely
induce diarrhea (Ahren and Svennerholm, 1985). CFs are highly
prevalent in different geographic regions of the world and rec-
ognized by specific receptors not yet described (Gaastra and
Svennerholm, 1996; Nataro and Kaper, 1998; Isidean et al., 2011).
Epidemiological studies have shown that CFs produced by ETEC
have immunogenic properties, and also have a protective immu-
nity, which can be achieved through multiple infections by the
host (Ahren and Svennerholm, 1985; Nataro and Kaper, 1998).
Human ETEC isolates express CS21 (Longus), a type IV
pilus (T4P), with >20μm in length. CS21 is expressed at 37◦C
when grown on blood agar plates and Pleuropneumoniae-Like
Organisms (PPLO) agar (Giron et al., 1994; Mazariego-Espinosa
et al., 2010). CS21 is composed of a single repeating structural
protein of 22-kDa called LngA. The lngA gene, encoding the LngA
major subunit, is contained in a large virulence plasmid of 90 kb
(Giron et al., 1994). The N-terminal amino acid sequence of the
LngA protein shares homology with the CofA (CFA/III) pilin sub-
unit ETEC, TcpA of V. cholerae, and BfpA of enteropathogenic
E. coli (Taylor et al., 1987; Girón et al., 1991, 1997; Giron et al.,
1994). The gene cluster organization and amino acid sequence
identity, suggest that these genetically diverse T4P may have a
common ancestor (Taniguchi et al., 2001).
CS21 plays an important role in the adherence to intestinal
epithelial cells (HT-29, Caco-2, and T84 cells) and display twitch-
ing motility activity; likewise, it was shown that CS21 assembly
is also influenced by nutritional growth conditions that phe-
notypically affect the expression of LngA (Mazariego-Espinosa
et al., 2010). In addition, CS21 is associated with bacterial self-
aggregation, protection against environmental stress, biofilm for-
mation, and adherence to primary intestinal epithelial cells and
recently (Guevara et al., 2013) demonstrated the role of CS21
in the pathogenesis of ETEC in vivo using a neonatal mice chal-
lenge infection model (Clavijo et al., 2010; Guevara et al., 2013).
Human-ETEC isolates encoding CFAs isolates from different geo-
graphic regions (Argentina, Bangladesh, Chile, Brazil, Egypt, and
Mexico), have shown a wide distribution of the lngA gene (Girón
et al., 1995a; Gutierrez-Cazarez et al., 2000; Pichel et al., 2002).
In addition to CS21, ETEC has another T4P called CFA/III for
which cofA is the major subunit, both are paralogous in nature
and belong to evolutionarily distinct types of fimbriae (Gomez-
Duarte et al., 2007); however, CFA/III has lower prevalence than
CS21 (Honda et al., 1984, 1985; Isidean et al., 2011). The aim of
this work was to genotypically and phenotypically characterize
a collection of clinical lngA+ ETEC isolates through PCR, resis-
tance profiles, self-aggregation properties, biofilm formation, and
adherence to HT-29 cells to further understand if these attributes
are related to the pathogenesis of CS21 positive clinical isolates
from children with diarrhea.
MATERIALS AND METHODS
BACTERIAL ISOLATES
Previously, clinical isolates identified as ETEC by serotyping were
obtained from an E. coli culture collection repository at the
Facultad de Medicina from Universidad Nacional Autónoma de
México (UNAM) for the last three decades. All clinical ETECwere
isolated from stool samples of children under 5 years old with
diarrhea from México and Bangladesh (Table S1). Isolates were
kept at −70◦C in Brain Heart Infusion broth (BHI, Difco, New
Jersey, USA) with 15% glycerol, until their use. The ETEC iso-
lates were cultured on 5% sheep blood agar plates (BBL, Franklin
Lakes, NJ) at 37◦C and on MacConkey agar (Difco, New Jersey,
USA).
IDENTIFICATION OF VIRULENCE GENES BY PCR
Genomic DNA was purified using a commercial Wizard kit
(Promega, USA) from a bacterial culture grown overnight in
Luria Bertani broth (LB, Difco, New Jersey, USA) at 37◦C. PCR
assays were performed using a commercial PCR kit (Promega,
USA) with the following reaction mixtures: 5μl of reaction
buffer [MgCl2 (50mM); Taq polymerase (0.l U), and dNTPs
(2mM)], 0.5μl of the forward primer (10μM), 0.5μl of the
reverse primer (10μM), 3μl of water, and 1μl of DNA (100 ng)
from each isolate. PCR reactions were conducted in a ther-
mal cycler (Applied Biosystems GeneAmp PCR system 9700,
NewYork, USA), with the specific melting temperature for each
primer (Table 1). PCR products were separated on a 1.5% agarose
gel in TAE (Tris-Acetate-EDTA) at 100 v, stained with ethid-
ium bromide (5μg/ml), and visualized by UV transilluminator
(Bio-Imaging Systems, AccesoLab, México, D.F., México). To
identify the st, lt, lngA, and cs3 and cfaI genes in clinical iso-
lates, the genomic DNAs of ETEC E9034A (O8:H9, st+, lt+,
lngA+, and cs3+ genes) and ETEC H10467 (cfaI+ gene) were
used as positive controls; whereas, the genomic DNA of E. coli
HB101 was used as negative control. Based on PCR results,
ETEC isolates positive for the lngA gene were selected for further
characterization.
IMMUNOBLOT
Whole cell extracts obtained from ETEC isolates positive for
lngA were harvested from PPLO (Difco, New Jersey, USA),
adjusted to the same concentration (OD600 = 1.0), boiled for
5min with sample buffer and subjected to sodium dodecyl-sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970;
Xicohtencatl-Cortes et al., 2007). Proteins separated in a 16%
SDS-PAGE were electroblotted onto nitrocellulose membranes
(Bio-Rad, Hercules, CA, USA) and then incubated with rab-
bit anti-CS21 antibodies (1:3,000 dilution) followed by incuba-
tion with a secondary goat anti-rabbit immunoglobulin G (IgG)
antibody conjugated to alkaline phosphatase (diluted 1:30,000).
Blots were developed with BCIP/NTM alkaline phosphatase
antibody detection reagent substrate (Millipore, Darmstadt,
Germany).
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Table 1 | Primer sequences, amplicon size, and melting temperatures used in this study.
Gene Primer Sequence 5′-3′ Size (bp) Tm (◦C) References
lngA F (J5) ATG AGC CTG CTG GAA GTT ATC ATT G 608 62 Mazariego-Espinosa et al., 2010
R (J6) TTA ACG GCT ACC TAA AGT AAT TGA GTT
st F ATT TTT CTT TCT GTA TTG TCT T 190 50 Perez et al., 2010
R CAC CCG GTA CAA GCA GGA TT
lt F GGC CAC AGA TTA TAC CGT GC 450 50 Levy, 2002
R CGG TCT CTA TAT TCC CTG TT
cfaI F GGT GCA ATG GCT CTG ACC ACA 478 55.7 This study
R AGT AGT ATC TCT TGT AAT GAC
cooA (csI) F GTC CAC ACC ATC AAC ACC GTT 320 62 This study
R ATT ATC CTG ACT AAG TCA ACG
cs3 F GGG CCC ACT CTA ACC AAA GAA 401 55.7 This study
R TTT AGT TTC AGG TAA TTA CCG
cofA (cfaIII) F ATC CTT TCG GTT TAT AACAGA ACG G 713 45 This study
R CGG CTC GCC AAA GTA ATA GAG
st: gene coding for a heat-stable enterotoxin; lt: gene coding for a heat-labile enterotoxin; lngA: gene coding for the major subunit of longus; cfaI: gene coding for
the colonization factor I; cooA: gene coding for the major subunit of CSI; cs3: gene coding for the CS3; cofA: gene coding for the major subunit of CFA/III.
ANTIBIOTIC SUSCEPTIBILITY
Antibiotic susceptibility test was determined for ETEC isolates
positive for the lngA gene by the Kirby-Bauer disk-diffusion
method as recommended by the Clinical and Laboratory
Standards Institute 2013 (CLSI-2013). Five colonies from
each isolate were grown in Mueller Hinton (MH) broth
(Becton Dickinson, Maryland, USA) at 37◦C with con-
stant shacking for 2–5 h until reaching an optical density
at 600 nm (OD600 nm) equivalent to 0.5 on the McFarland
scale. MH agar plates were massively seeded with bacte-
rial suspension using a sterile swab. Discs with the appro-
priate antibiotics were placed on the inoculated plates and
incubated at 37◦C for 18–24 h. For susceptibility testing a
total of 12 antibiotic categories were used: cephalosporins
I/II: 30μg cephalothin (Becton Dickinson, Maryland, USA)
and 30μg cefaclor (Becton Dickinson, Maryland, USA); car-
bapenems: 10μg meropenem (Oxoid Sunnyvale, California,
USA) and 10μg imipenem (Becton Dickinson, Maryland,
USA); quinolones: 30μg nalidixic acid (Becton Dickinson,
Maryland, USA); penicillins: 10μg ampicillin (Becton Dickinson,
Maryland, USA); β-Lactam/ β-lactamase inhibitor combi-
nation: 20/10μg amoxicillin-clavulanate (Becton Dickinson,
Maryland, USA), 100/10μg piperacillin-tazobactam (Oxoid
Sunnyvale, California, USA), and 75/10μg ticarcillin-clavulanate
(Oxoid Sunnyvale, California, USA); tetracyclines: 30μg tetra-
cycline (Becton Dickinson, Maryland, USA); folate path-
way inhibitors: 1.25/23.75μg trimethoprim-sulfamethoxazole
(Becton Dickinson, Maryland, USA); aminoglycosides: 10μg
gentamicin (Becton Dickinson, Maryland, USA) and 30μg
amikacin (Becton Dickinson, Maryland, USA); phenicols: 30μg
chloramphenicol (Becton Dickinson, Maryland, USA); fluoro-
quinolones: 5μg ciprofloxacin (Becton Dickinson, Maryland,
USA); nitrofurans: 300μg nitrofuratoin (Becton Dickinson,
Maryland, USA); monobactams: 30μg aztreonam (Becton
Dickinson, Maryland, USA); and cephalosporin III/IV: 30μg cef-
triaxone (Becton Dickinson, Maryland, USA), 30μg ceftazidime
(Becton Dickinson,Maryland, USA), and 30μg cefepime (Becton
Dickinson, Maryland, USA). Inhibition zones were determined
and interpreted according to the recommendations of the CLSI-
2013. E. coli ATCC (American Type Culture Collection) 25922
was used as quality control.
SELF-AGGREGATION ASSAY
The bacterial self-aggregation phenotype was analyzed using flat-
bottom 24-well tissue culture plates (Corning, NY, USA); the
assay consists of bacterial clumping during growth in liquid
media. Bacteria grown overnight in Terrific broth (TB) (Amresco
LLC, Ohio, USA) at 37◦C were subcultured using a 1:100 dilu-
tion and incubated at 37◦C in TB for 4 h. Self-aggregates were
visualized directly on a bacterial suspension by an inverted light
microscope (Olympus, Center Valley, PA) (Clavijo et al., 2010).
Triplicates of the assays were performed at three different times.
ETEC isolates: E9034A and lngA− clinical isolate 114246 (back-
ground: O132:H25, st+, lt+, ecpA+) were used as positive and
negative controls, respectively. To establish the role of lngA in self-
aggregation, a comparison between isogenic mutants E9034A vs.
E9034lngA::km and 73332 vs. 73332lngA::km was made.
BIOFILM FORMATION
ETEC clinical isolates lngA positive were quantitatively analyzed
according to the protocol described by Saldaña et al. (2009). In
brief, 24-well plates containing 1ml of PPLO were inoculated
with 10μl (1.5 × 108 bacteria/ml) of bacterial suspensions and
incubated at 37◦C for 24 h. Biofilms on the surface of the wells
were slowly washed three times with phosphate buffer saline 1x
(PBS) (pH 7.4) and fixed with 2% formalin at 4◦C overnight.
Wells with fixed biofilms were decanted, washed three times with
PBS and stained with 1ml of 1% crystal violet for 20min. The
excess of crystal violet was removed and the plates washed with
water twice. Subsequently, 1ml of 70% methanol was added for
biofilm quantification by measuring optical density at 600 nm.
Assays were made in Triplicates and repeated three consecutive
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times. Enteroaggregative E. coli 042 and ETEC lngA− clinical
isolate 114246 were used as positive and negative controls, respec-
tively. ETEC lngA− absorbance was used to classify the biofilm
formation into four categories as described by Saxena et al.
(2014): non-biofilm, weakly, moderately, or strongly biofilm for-
mers based upon the ODs of bacterial films (Saxena et al., 2014).
The cut-off OD600 nm for a 24 wells-plates is defined as two stan-
dard deviations above the mean OD600 nm of the negative control.
To establish the role of lngA in biofilm formation, a comparison
between isogenicmutants E9034A vs. E9034lngA::km and 73332
vs. 73332lngA::km was performed.
BACTERIAL ADHERENCE TO HT-29 CELLS
Colon adenocarcinoma HT-29 cells (ATCC HTB-38) were
employed for the adherence assays, as described by Mazariego-
Espinosa et al. (2010). Clinical ETEC lngA positive isolates were
grown in PPLO overnight at 37◦C. Cell monolayers contained
in 24-well polystyrene plates (Corning, NY, USA), were cul-
ture in Dulbecco’s minimal Eagle medium (DMEM) (Invitrogen,
Carlsbad, CA) supplemented with 10% FBS (Fetal Bovine Serum)
(Gibco, USA) at 37◦C under 5% CO2 until reaching an 80%
confluence. The monolayers were infected with 10μl of each
bacterial suspension to an OD600 nm of 0.5 in the McFarland
scale and incubated for 4 h at 37◦C and 5% CO2. Infected
monolayers were washed three times with 1x PBS (pH 7.4) to
remove unbound bacteria and incubated of 0.1% Triton-100x
(Amresco Bioscience, Sweden) for 5min; serial dilutions were
plated on LB, incubated at 37◦C for 24 h, and colony forming
units (CFU) counted to determine CFU/ml. Adhesion assays were
performed in triplicate and on three different days. Adherence
values correspond to averages of triplicate assay and the corre-
sponding standard deviation. ETEC isolates adherence was clas-
sified with cut-off CFU/ml for Enteroaggregative E. coli 042 is
defined as two standard deviations above the mean of the positive
control.
CONSTRUCTION OF AN lngA ISOGENIC MUTANT
The lambda red system was used to construct an isogenic mutant
of the lngA gene in clinical isolate 73332 and the E9034A as
described by Datsenko and Wanner (2000), Mazariego-Espinosa
et al. (2010), and Mazariego-Espinosa et al. (2010). Briefly, the
kanamycin resistance (kmr) cassette from plasmid pKD4 was
amplified using the following primers lngA F (5′ ttgagtttacct-
gagcagtacaggtacttagaattttgtctgcagtcaaggtgtagggctggagctgct tc 3′)
and lngA R: (5′ tgctatccgtgtataaccggacacagaaatttaaagaagaggcaa-
gaaaacatatgaatatcctccttag 3′). The PCR-assay was performed in
a 200μl reaction mixture containing 10mM Tris-HCl, 3mM
MgCl2, 200μM deoxynucleoside triphosphates (dNTPs), 2U of
DNA polymerase, 0.25μM each primer, and 10μl of template
DNA. The PCR products obtained were electroporated into ETEC
clinical isolate 73332 and E9034A, harboring the pKD46 plasmid,
and transformants were selected for kanamycin resistance.
STATISTICAL ANALYSIS
The results showed are the mean of three experiments performed
in triplicate on different days. Statistical analysis was done using
the Student’s t-test.
RESULTS
IDENTIFICATION OF CS21 AMONG ETEC CLINICAL ISOLATES FROM
CHILDRENWITH DIARRHEA
A total of 303 clinical isolates previously identified as ETEC by
serotyping, were obtained from Mexican and Bangladeshi chil-
dren stool and screened by PCR for the following genes: st, lt,
lngA, cs1, cs3, cfa/I, and cofA. Eighty one point fifty one percent
(247/303) of the isolates amplified at least one gene (Table 2). The
most frequent genotypes identified for the ETEC isolates were:
st+/lt+ with 30.76% (76/247); lt+ 30.36% (75/247); st+ 11.33%
(28/247); lt+/lngA+ 7.69% (19/247), and st+/ lt+/ lngA+ with
5.26% (13/247). Differences between geographical regions were
observed: in Bangladeshi isolates the st+/lt+ genotype was the
most prevalent with 37% (75/201); in contrast Mexican isolates
showed a prevalence of lt+ genotype of 48% (22/46) (Table 2).
CS21 ETEC ISOLATES CARRY VARIABLE ENTEROTOXIGENIC VIRULENCE
GENES
According to Isidean et al. (2011), CS21 is perhaps one of
the most prevalent CF worldwide (Isidean et al., 2011). The
present study was addressed toward ETEC isolates, which pos-
sess the lngA gene coding for the LngA protein, the struc-
tural subunit of Longus. The results showed that the lngA gene
was amplified in 25.10% (62/247) of the isolates. The lngA+
gene was associated to lt+ 33.87% (21/62), st+/lt+ 33.87%
(21/62), st+19.35% (12/62), cfaI+17.74% (11/62), cs3+ 6.45%
Table 2 | Genotype detection frequency of ETEC isolates from
children with diarrhea.
Genes Percentage Mexican Bangladesh
(positive isolates) percentage percentage
(positive isolates) (positive isolates)
st+/lt+ 30.76 (76) 2.17 (1) 37.31 (75)
lt+ 30.36 (75) 47.83 (22) 26.37 (53)
st+ 11.33 (28) 8.70 (4) 11.94 (24)
lt+/lngA+ 7.69 (19) 8.70 (4) 7.46 (15)
st+/lt+/lngA+ 5.26 (13) 2.17 (1) 5.97 (12)
lngA+ 2.83 (7) 10.87 (5) 0.99 (2)
st+/lngA+ 2.83 (7) 2.17 (1) 2.99 (6)
st +/lngA+/cfaI+ 2.42 (6) 4.35 (2) 1.99 (4)
st+/lt+/lngA+/
cfaI+
2.02 (5) 0 2.49 (5)
st+/lt+/lngA+/
cs3+
1.21 (3) 6.52 (3) 0
st+/lt+/cs3+ 0.8 (2) 2.17 (1) 0.50 (1)
lt+/cs3+ 0.8 (2) 0 0.99 (2)
lt+/csI+ 0.4 (1) 2.17 (1) 0
st+/csI+ 0.4 (1) 0 0.50 (1)
st+/lt+/lngA+/
csI+/cs3+
0.4 (1) 2.17 (1) 0
lt+/lngA+/cofA+ 0.4 (1) 0 0.50 (1)
Total 100 (247) 99.99 (46) 100 (201)
st, gene coding for heat-stable enterotoxin; lt, gene coding for heat-labile entero-
toxin; lngA, gene coding for the major subunit of longus; cfaI, gene coding for
the colonization factor I; cooA, gene coding for the major subunit of CSI; cs3,
gene coding for the CS3; cofA, gene coding for the major subunit of CFA/III.
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(4/62), cs1+ 1.61% (1/62), and cofA+ 1.61% (1/62) genes.
Association of lngA with lt+ Bangladeshi isolates was 36%
(15/42) and, just the lngA+ genotype alone with a 25% (5/20)
was found in Mexican isolates. Expression of LngA in lngA+
ETEC isolates was determined by immunoblot. Fifty percent
(31/62) of the isolates analyzed produced LngA, protein pro-
duction distribution was similar in both geographic regions:
Mexican 65% (13/20) and Bangladesh 42.9% (18/42). These
data suggest that even though the isolates encode the LngA
protein, specific regulatory signals may be necessary to trig-
ger LngA expression in the remaining 50% of the clinical
isolates.
SEROTYPING OF ETEC ISOLATES
Thirty-one serotypes were identified in lngA+ ETEC isolates
(Table S1). Three main serotypes prevailed: O128ac:H12 in
19.35% (12/62), O78:H12 andO6:H16 with 11.29% (7/62). These
serotypes showed a strong association between the lngA+ gene
with the lt+ and st+/lt+ genes (Table S1).
ETEC ISOLATES WERE MULTIDRUG-RESISTANT (MDR)
Multidrug-resistance defined as antibiotic resistance to at least
three antibiotic categories is widespread among foodborne and
waterborne enteric pathogens including ETEC. While ETEC
treatment is not based on antibiotics in the majority of cases,
evaluating antibiotic susceptibility is important in cases where
antibiotic use is clinically indicated. In this study, 62 lngA+ ETEC
isolates were tested for resistance to different antibiotic cate-
gories. Interestingly, 96.77% (60/62) of the isolates were resistant
to at least one antibiotic category. Resistance to first and sec-
ond generation cephalosporins was observed in 76.66% (46/60)
of the isolates; to fluoroquinolones in 70% (42/60); to peni-
cillin and tetracyclines in 50% (30/60); to β-Lactam/ β-lactamase
inhibitor combination in 43.33% (26/60); and to folate path-
way inhibitors 28.33% (17/60). ETEC antibiotic resistance to the
remaining antibiotic categories was less than 17% (Figure 1).
Only one ETEC isolate was resistant to a third generation
cephalosporin; therefore, an Extended Spectrum Beta Lactamases
(ESBL) assay was performed, and resulted positive for this test
(Table S1).
Multidrug-resistance was identified among 65% (39/60) of the
lngA+ ETEC isolates, based on geographic regions, distribution of
MDR clinical isolates were from Bangladesh with 76.2% (32/42),
compared with Mexican isolates with 35% (7/20) (Table S1).
The association of multidrug-resistance to some genotypes was
determined after observing the following distribution: 28.20%
(11/39) to lngA+/st+/lt+; 25.64% (10/39) to lngA+/lt+; 15.38%
(6/39) to lngA+/st+; 12.82% (5/39) to lngA+; 12.82% (5/39)
to lngA+/lt+/st+/cfaI+; and 5.12% (2/39) to lngA+/st+/cfaI+
genotypes, respectively (Figure 2).
FIGURE 1 | Resistance profiles for ETEC positive isolates for the lngA
gene. Sixty-two ETEC isolates were tested for resistance against different
antibiotic categories. ∗One ETEC isolate was resistant to a third generation
cephalosporin, therefore an Extended Spectrum Beta Lactamases (ESLB)
assay was performed, and was positive for this test. n = number of positive
ETEC lngA isolates.
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FIGURE 2 | Genotypes found in MDR ETEC isolates positive for the
lngA gene. Sixty-five percent (39/60) of ETEC isolates were resistant to at
least three antibiotic families. The association of multidrug-resistance to the
genotypes was determined. n = number of positive ETEC lngA isolates.
CS21 POSITIVE ETEC ISOLATES SELF-AGGREGATE
Self-aggregation was visualized in 48.38% (30/62) of the ETEC
isolates analyzed. Self-aggregation distribution in the geographic
regions was as follows: Mexican 60% (12/20) and Bangladesh
42.9% (18/42). This phenotype was classified as weak (+), mod-
erate (++), and strong (+ + +) according to the levels of
aggregation observed in ETEC strain E9034A, used as positive
control. Figure 3 showed the self-aggregation patterns of E9034A
(weak), 115340 (moderate), and 45162 (strong) ETEC isolates.
Accordingly, 23.33% (7/30), 46.66% (14/30), and 30% (9/30) of
the ETEC isolates showed a weakly, moderately, and strongly self-
aggregation, respectively (Figure 3). Interestingly, 76.66% (23/30)
of ETEC isolates expressing LngA exhibited self-aggregation, sug-
gesting that CS21 among ETEC clinical isolates is strongly asso-
ciated to this phenotype. The remaining clinical isolates 21.87%
(7/32) were unable to express LngA and showed a weak or moder-
ate self-aggregation phenotype, suggesting that CS21 contribute
to the aggregate formation. To corroborate the role of lngA in
self-aggregation, a comparison between isogenic mutants E9034A
vs. E9034lngA::km and 73332 vs. 73332lngA::km was made, in
which the loss of the phenotype was observed in both mutants
(Figure S1).
CS21 ETEC ISOLATES FORM BIOFILM
Biofilm formation is a critical event for bacterial pathogen-
esis. ETEC lngA− clinical isolate 114246 was used as nega-
tive control and its absorbance was used to classify as weakly
biofilm former (0.129–0.258); moderately biofilm former (0.259–
0.516); and strongly biofilm former (≥0.517) (Table 3). Among
lngA+ ETEC, 83.87% (52/62) formed biofilm, grouping them as:
40.38% (21/52) weakly biofilm formers; 46.15% (24/52) moder-
ately biofilm formers, and 13.46% (7/52) strongly biofilm for-
mers (Figure 4). Interestingly, 48.07% (25/52) of ETEC clinical
isolates producing the LngA protein detected by immunoblot
were associated to different levels in biofilm formation. Of
those, 32% (8/25), 48% (12/25), and 20% (5/25) ETEC iso-
lates were weakly, moderately, and strongly biofilm formers,
FIGURE 3 | Self-aggregation in ETEC isolates positive for the lngA
gene. Forty-eight point eighty-three percent of ETEC isolates analyzed
showed weakly (E9034A), moderately (115340), and strongly (45162)
self-aggregation phenotypes. n = number of positive ETEC lngA
isolates.
Table 3 | Classification of lngA+ ETEC isolates for biofilm formation.
OD600nmvalue Biofilm forming
OD ≤ ODc <0.129 Non
ODc < OD ≤ 2 ODc 0.129–0.258 Weak
2 × ODc< OD ≤ 4 × ODc 0.259–0.516 Moderate
4 × ODc< OD ≥0.517 Strong
ODc, Optical density cut off value: average OD of negative control.
respectively. To corroborate the role of lngA in biofilm forma-
tion, a comparison between isogenic mutants E9034A (0.1824
OD600 nm) vs. E9034lngA::km (0.1214 OD600 nm) and 73332
(0.1459 OD600 nm) vs. 73332lngA::km (0.1262 OD600 nm) was
made, where the statistical analysis showed no statistical signifi-
cance (p = 0.27) and (p = 0.46), respectively.
ETEC ISOLATES WERE ABLE TO STRONGLY ADHERE TO HT-29 CELLS
The HT-29 cells were infected with ETEC isolates positive for
the lngA gene and the results showed different adherence val-
ues after the quantification. HT-29 cell adherence distribution
was similar in both geographic regions. The adherence levels
ranged from 0.3 × 106 to 57.5 × 106 CFU/ml (Figure 5). The
classification of adherence was done according to the positive con-
trol (Enteroaggregative E. coli 042) mean (11.97 × 106 CFU/ml),
grouped in three phenotypes: weakly (0.3–2.99 × 106 CFU/ml),
moderately (3.0–5.98 × 106 CFU/ml), and strongly adherent
(≥5.99 × 106 CFU/ml). Briefly, 22.58% (14/62), 25.80% (16/62),
and 51.62% (32/62) of lngA+ ETEC isolates were weak, mod-
erate, and strong adherent. The relationship between LngA
expression and adherence was as follows: 29.03% (9/31) for
weak and moderate adherent, and 41.94% (13/31) for strong
adherent.
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FIGURE 4 | Biofilm in ETEC isolates positive for the lngA gene. From
the 62 lngA+ ETEC isolates analyzed, 83.87% were able to form biofilm.
Biofilm formation is critical in the pathogenesis of many human bacterial
pathogens. ETEC lngA− was used as negative control and its absorbance to
classify as weakly biofilm formers (0.129–0.258); moderately biofilm
formers (0.259–0.516); and strongly biofilm formers (≥0.517).
Enteroaggregative E. coli 042 shows as rhomb on gray (positive control).
FIGURE 5 | Adherence in ETEC isolates positive for the lngA gene.
Quantitative adherence assay determined in CFU when HT-29 cells were
infected. The classification of adherence was done according to the positive
control (Enteroaggregative E. coli 042) mean (11.97 × 106 CFU/ml), grouped
in three phenotypes: weakly (0.3–2.99 × 106 CFU/ml), moderately
(3.0–5.98 × 106 CFU/ml), and strongly adherent (=5.99 × 106 CFU/ml).
Enteroaggregative E. coli 042 shows as rhomb on gray (positive control).
Clinical isolate 73332 serotype O6:H6 carrying lt+, st+, cs3+,
and lngA+ was selected to study the role of CS21 in the adher-
ence to HT-29 cells. This isolate expresses LngA and was clas-
sified as highly adherent (8.48 × 106 CFU/ml). The adherence
levels were compared among ETEC wild-type (E9034A and
73332) and isogenic mutants (E9034AlngA and 73332lngA).
Reduction of 98% (1.55 × 105 CFU/ml) cell adherence with
ETEC 73332 isolate (8.48 × 106 CFU/ml) compared to 77%
(9.33 × 105 CFU/ml) reduction in ETEC E9034A strain (3.97 ×
106 CFU/ml) demonstrates that the reduction in the adherence
was attributed to the lngA gene mutation (Figure 6A). A statis-
tical difference in cell adherence reduction was observed when
the lngA gene was deleted in ETEC clinical isolate 73332 and
ETEC E9034A, with p-values of 0.0001 and 0.0006, respectively.
FIGURE 6 | Role of Longus in ETEC isolates E9034A and 73332. (A)
Quantitative adherence assay in CFU after 6 h of infection to HT-29 cells.
The percentage of each isolate is shown in a bar graph. (B) Growth curve in
PPLO medium to corroborate growth rate among wild type isolates and
isogenic mutants in the lngA gene. h, hours.
A growth kinetic curve with wild type ETEC and lngA mutants
was performed in PPLO media (Figure 6B) showing that there
was no difference in growth among the wild-type and isogenic
mutants ETEC isolates.
DISCUSSION
ETEC isolates are a frequent cause of diarrhea worldwide; ETEC
causes nearly 400 million diarrhea episodes every year affecting
children from developing countries as well as travelers (Wenneras
and Erling, 2004; Riddle et al., 2006). ETEC colonizes the small
bowel epithelium trough the expression of fimbrial and non-
fimbrial CFs and producing LT and/or ST enterotoxins causing
massive excretion of water and electrolytes (Qadri et al., 2005;
Turner et al., 2006; Guttman and Finlay, 2008; Croxen and Finlay,
2010). After screening CFs in ETEC isolates from different geo-
graphical origins, CFA/I and Longus are the most prevalent CFs
(Giron et al., 1994; Girón et al., 1995a; Gutierrez-Cazarez et al.,
2000; Pichel et al., 2002). A strategy to control enterotoxigenic
E. coli infections has been the development of a vaccine that trig-
gers protective immunity against the most prevalent CFs (Giron
et al., 1994; Girón et al., 1995a; Gutierrez-Cazarez et al., 2000;
Pichel et al., 2002). In this study we analyzed a total of 303 clinical
isolates obtained from Mexican and Bangladeshi children stools,
classified as ETEC by serotyping. The st+/lt+ (30.76%) was the
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most frequent genotype amplified for ETEC isolates analyzed in
this study and the frequency was higher than previously reported
by Guerra et al. (2014), in which only 15% of ETEC isolates
from Colombia were positive for both enterotoxin genes (Guerra
et al., 2014). However, a systematic review by Isidean et al. (2011),
reported a global distribution of st+/lt+ of 33% in ETEC clini-
cal isolates, similar to the findings in this study. The frequency of
the lngA gene among ETEC clinical isolates in several countries
may vary between 8.5 and 50% (Girón et al., 1995a; Gutierrez-
Cazarez et al., 2000; Nishimura et al., 2002; Pichel et al., 2002;
Guerra et al., 2014). Meanwhile, in this study the lngA gene was
amplified in 25.10% of the isolates. A lower frequency of the
lngA+ gene associated to st+, st+/lt+, and lt+ genes was observed
when compared with data described by Nishimura et al. (2002);
which reported a frequency of 56%, 31%, and 10%, respectively
(Nishimura et al., 2002). Likewise, lngA-positive ETEC isolates
(25.10%) also harbor genes coding for other CFs. In other reports,
lngA+ was most highly associated to isolates coding for CFA/II
(Girón et al., 1995b; Nishimura et al., 2002) and CFA/I that has
been described as the most prevalent CF in developing countries.
However, in this study it appeared in low frequency 6.45%, for
cfaII (csI, cs3), and 17.74% for cfaI (Pichel et al., 2002; Qadri et al.,
2005). Interestingly, lngA+ isolates were found alone in 11.29%
of the ETEC isolates. This result suggest that these isolates could
have lost the plasmid that code for enterotoxins, leaving only
the megaplasmid coding for lngA+; therefore, lngA is proposed
as a molecular marker together with lt and st genes, for iden-
tification of the ETEC pathotype. The most prevalent serotypes
found in ETEC lngA+ isolates were O128ac:H12, O78:H12, and
O6:H6. The lngA gene was also described in a considerable
number of ETEC serotypes (O2:NT, O6:NM, O6:H2, O6:H16,
O6:H48, O8:H2, O8:H6, O8:H21, O8:H29, O20:H2, O25:NM,
O25:H42, O49:NM, O128:NM, O139:H28, O148:H28, O153:H2,
O153:H45, O158:H10, and O159:H4) (Girón et al., 1995a). These
data provide further evidence of the wide distribution of CS21
among ETEC clinical isolates.
The frequency up to date reported for MDR ETEC isolates
is 46.4% (Zeighami et al., 2014). In this study, 65% of ETEC
isolates positive for lngA, were multidrug-resistant to different
antibiotic categories. In particular, resistance to cephalosporins I
and II (76.66%), fluoroquinolones (70%), penicillins and tetracy-
cline (50%), β-lactam/β-lactamase combination (43.33%), folate
pathway inhibitors (28.33%); and for the rest of the antibiotic
categories (aminoglycosides, phenicols, quinolones, nitrofurans,
monobactams, and cephalosporin III and IV) we found less than
17% of resistance. In contrast to the reports from other stud-
ies in which ampicillin, trimethoprim-sulfamethoxazole, cefa-
zolin, and amoxicillin-clavulanate resistance was detected among
67.5%, 50%, 15%, and 5% isolates, respectively. In addition,
no resistance to ceftriaxone, ceftazidime, cefepime, ciprofloxacin,
and piperacillin-tazobactam was detected among ETEC isolates
(Guerra et al., 2014). In other study, 47% of ETEC isolates were
resistant to ampicillin, a third (37%) of the isolates was resistant
to trimethoprim-sulfamethoxazole, and 24% of the isolates were
tetracycline-resistant (El-Gendy et al., 2013).
Although the treatment of diarrhea caused by ETEC with
antibiotic agents is generally restricted to severe and moderate
hospitalized cases or immunocompromised patients, there is an
increased number of clinical isolates of MDR ETEC, which could
be a potential public health problem; for this reason, the study
of antibiotic resistance should be carried out in combination with
the frequencies of CFs and enterotoxins. We found that 46.15% of
MDR ETEC isolates was able to produce the LngA protein. In this
study ETEC isolates were MDR and producers of the LngA pro-
tein providing the bacteria colonization and pathogenic advan-
tages. CS21, a type IV pilus and a common CF in ETEC, induce
microcolony formation, twitching motility, adherence to cells,
and self-aggregation (Clavijo et al., 2010; Mazariego-Espinosa
et al., 2010). Self-aggregation has been associated to bacterial
protection against antibiotics in a similar manner as bacterial
biofilms avoid contact with lumen intestinal bactericidal agents
such as lactoferrin, lysozyme, and secretory antibodies. In this
study, 48.38% of the ETEC isolates were able to self-aggregate and
76.66% of the ETEC isolates produced the LngA protein.
Biofilms are matrix-enclosed communities of bacteria that
show increased antibiotic resistance and the ability to evade
the immune system (MacFarlane and Dillon, 2007). They can
cause recalcitrant infections which cannot be cured with classical
antibiotic therapy (Forier et al., 2014). Biofilm production and
adherence mechanisms of ETEC isolates are associated with CFs
and multiple genes coding for CFs located on a plasmid (CFA/I
and CFA/II), as well as on its chromosome (CS2). In our study,
83.87% of the ETEC isolates tested were able to form biofilm at
24 h. Liaqat and Sakellaris (2012), described that all ETEC iso-
lates analyzed were able to form biofilm after 60 h (Liaqat and
Sakellaris, 2012). Outstandingly, most of the ETEC isolates were
weak and moderate biofilm producers and a relationship was not
found.
Many pathogenic bacteria have the ability to adhere to spe-
cific host tissues prior to colonization. Thus, bacterial adhesion
is the initial step that precedes colonization and in some cases
invasion of the epithelial surfaces (Pizarro-Cerda and Cossart,
2006). All ETEC isolates were able to adhere to HT-29 cells,
and the isolates that produce the LngA protein were associated
with high adherence values. Mazariego-Espinosa et al. (2010),
demonstrated that CS21 produced by ETEC E9034A is involved
in the phenomenon of adherence as a requirement for mediat-
ing the interaction between the bacteria and cultured epithelial
cells, specifically intestinal cells (Mazariego-Espinosa et al., 2010).
In this study, we demonstrate the role of CS21 for adhesion,
using the E9034A prototype strain that has been widely used in
other studies and a clinical isolate 73332. The aim was to analyze
through quantitative studies the potential of CS21 as an adhesin
in clinical isolates of ETEC during the colonization to their host.
The growth curve kinetic was performed to guarantee that
the adherence phenotype was not affected by bacterial growth.
Isogenic mutants in the lngA gene showed a reduction of adher-
ence from 77% to 98.8%. However, Mazariego-Espinosa et al.
(2010) showed a reduction of 32% in adherence levels in the
E9034AlngA when compared to ETEC E9034A (Mazariego-
Espinosa et al., 2010). The difference observed in adherence levels
in both mutants, could be attributed to the generation of a sec-
ond mutant in the lngA gene employed in this study from a
highly adherent colony of the E9034A wild-type strain; which,
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was previously selected from multiple subcultures in HT-29 cells
in different days.
Antibiotic categories such as sulfonamides and beta-lactam
containing compounds can be effective prophylaxis against trav-
eler’s diarrhea by deficiency of effective vaccine treatments
(Brown et al., 2009) this can be explained by the different
geographical origins of the Mexican and Bangladeshi isolates.
However, the emergence of antibiotic resistant isolates and the
genes encoding resistance proteins are known to reside on hor-
izontal transmissible elements such as conjugative plasmids and
integrons promoting the spread of resistance (Levy, 2002). The
MDR ETEC isolates able to produce LngA showed features asso-
ciated with self-aggregation, and adherence to intestinal cell lines.
These features are important in the colonization process. Taking
into consideration the frequencies of occurrence of the widely
spread CFs such as CFA/I and CS21 in other geographic regions,
the frequencies of occurrence of the lngA pilin gene found here or
described by others confirm the importance of the CS21 pilus as
a widely distributed antigen among ETEC isolates.
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